Background-Viral myocarditis is among the most common causes of heart failure in children and young adults. The RNA helicase melanoma differentiation-associated gene-5 (MDA5) is critical for host antiviral responses against members of the Picornaviridae family, such as encephalomyocarditis virus (EMCV). MDA5-knockout mice are highly susceptible to EMCV infection and develop significant myocardial injury and left ventricular dysfunction. However, the mechanisms by which MDA5 signaling within cardiac myocytes contributes to the host response against viral infection have not been defined. Methods and Results-We generated cardiac-specific MDA5 transgenic (alpha-myosin heavy chain [αMHC]-MDA5) mice. These mice showed increased baseline cardiac expression of antiviral cytokines and increased cellular infiltration but no alterations in cardiac function and structure. αMHC-MDA5 mice were less susceptible to EMCV infection and had a significantly lower cardiac viral load compared with littermate control mice. The severity of myocarditis, prevalence of cardiac myocyte apoptosis, and cleavage of caspase 3 after EMCV infection were attenuated in αMHC-MDA5 mice. Furthermore, αMHC-MDA5 mice were protected against EMCV-induced myocardial dysfunction. Conclusions-Our data suggest that myocardial MDA5 may be a key molecule in protecting the heart from direct viral injury and myocardial dysfunction. (Circ Heart Fail. 2013;6:326-334.)
V iral infections of the heart are important causes of morbidity and mortality in children and young adults. 1 Recent evidence suggests that cardiac myocytes possess a functionally intact innate immune system that becomes activated in response to many forms of acute injury, including viral infection. [2] [3] [4] Over the past decade, our understanding of the innate immune mechanisms that recognize and respond to viral invasion has greatly expanded. The retinoic-induced gene-I-like receptors, including retinoic acid inducible gene I (RIG-I), melanoma differentiation-associated gene-5 (MDA5; also known as interferon induced with helicase C domain or IFIH1), and Laboratory of Genetics and Physiology 2 (LGP2), are major components of the RNA virus detection system in mammals. 5 In contrast to toll-like receptor 3 (TLR3) that primarily recognizes double-stranded RNA from within the endosome, retinoic-induced gene-I-like receptors function as cytoplasmic sensors of double-stranded RNA. Recent studies have shown that MDA5 is associated with the detection of members of the Picornaviridae family, such as encephalomyocarditis virus (EMCV). 4, [6] [7] [8] Consistent with this observation, MDA5-knockout (KO) mice succumbed after EMCV infection as result of direct viral injury to the heart leading to severe myocardial dysfunction. Similar observations have been reported in the setting of acute coxsackievirus B3 (CVB3) infection in MDA5-KO mice, suggesting that MDA5 signaling may play a critical role in protecting the heart during acute viral infection. 9 Recently, we have shown that mice with conditional cardiac-specific-overexpression of the TLR3/TLR4 adaptor molecule TIR-domain-containing adapter-inducing interferon-β (TRIF) are protected against EMCV-induced mortality, myocarditis, and left ventricular (LV) dysfunction. 10 An interesting observation that arose from these studies was that the expression of MDA5 was significantly increased in the hearts of TRIF transgenic mice. This raised the intriguing possibility that MDA5 expression could contribute to the protective phenotype observed in the TRIF transgenic mice. transgenic mice with cardiac-specific expression of MDA5 and challenged with a myocarditic variant of the EMCV. Here, we show that cardiac-specific overexpression of MDA5 results in the upregulation of antiviral molecules that are essential for efficient control of EMCV, attenuates EMCV-induced myocarditis and cardiac myocyte apoptosis, and prevents EMCV-induced myocardial dysfunction. These findings highlight a crucial role for cardiac MDA5 in the setting of acute viral myocarditis.
Methods

Generation of Cardiac-Specific MDA5 Transgenic Mice
A transgenic construct containing a 3-kb mouse MDA cDNA was produced by subcloning the c-myc-tagged mouse MDA5 cDNA into the SalI/HindIII cloning sites downstream of the alpha-myosin heavy chain (αMHC) promoter (provided by J. Robbins, University of Cincinnati). Southern hybridization was used to detect transgene expression in the heart, and c-myc Western blot was used to detect the c-myc-tagged MDA5 protein.
MDA5-KO mice were provided by Drs Gitlin and Colonna (Washington University School of Medicine). 7 All experiments were approved by the Institutional Animal Care and Use Committee at Baylor College of Medicine and were performed in compliance with the National Institutes of Health regulations for animal handling and usage.
Western Blot
Protein was separated on 12% SDS-PAGE under denaturing conditions. The membrane was immunoblotted with rabbit anti-c-myc and GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA). The secondary antibody was horseradish peroxidase-conjugated goat anti-rabbit polyclonal antibody (1:1000; Santa Cruz Biotechnology).
Myocardial Cytokine ELISA
Cardiac tumor necrosis factor (TNF), CXCL10, interferon (IFN)-γ, and IFNβ proteins were measured by ELISA (R&D Systems, Minneapolis, MN). Data were expressed as picogram/milligram of protein.
Real-time Reverse Transcriptase Polymerase Chain Reaction Analysis
Predeveloped murine TagMan Gene Expression Assays were purchased from Applied Biosystems: Mx1, IRF7, Isg15, Oas2, and GAPDH. Relative gene expression was calculated by the delta-delta Ct method. Expression of target genes was normalized to GAPDH and reported as fold change versus the appropriate control.
Echocardiographic Analysis
Studies were performed in the Mouse Phenotyping Core at Baylor College of Medicine as previously described. 10
Immunohistochemistry
Immunohistochemistry was performed on paraffin-embedded heart tissue as previously described. 10 The pan-leukocyte marker, rat antimouse CD45 (BD PharMingen; 1:500) was used to stain infiltrating cells. Biotinylated, horseradish peroxidase-tagged anti-rat antibody (Vectastain ABC Kit; Vector Laboratories, Burlingame, CA) was used as a secondary antibody at a dilution of 1:200.
Quantification of Inflammatory Cells
The level of inflammation was determined morphometrically as the volume fraction (% vol) of stained myocardium containing inflammatory cells (CD45 + ) per high-power field using an unbiased stereological technique as previously described. 10
Viral Inoculation and Titers
Six-week-old male and female littermate (LM), αMHC-MDA5, and MDA5-KO mice were inoculated intraperitoneally with 50 plaque-forming units of EMCV. Viral titers were determined as previously described. 11
Measurement of Serum Cardiac Troponin I Levels
Serum cardiac troponin I levels were measured with a commercially available kit (Life Diagnostics, West Chester, PA).
Detection of Apoptosis
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay was performed using the ApopTaq Plus apoptosis detection kit (Millipore Corp, Billerica, MA). See online-only Data Supplement for details.
Cleaved Caspase 3 Western Blot
The membrane was immunoblotted with rabbit anti-cleaved caspase 3 antibody (1:1000; Cell Signaling) and anti-GAPDH antibody (1:5000; Santa Cruz Biotechnology). The secondary antibody was horseradish peroxidase-conjugated goat anti-rabbit polyclonal antibody (1:1000; Santa Cruz). For each sample, band density (measured in arbitrary units) was evaluated using ImageJ analysis software.
Statistical Analysis
All values were expressed as mean±SEM. A Kaplan-Meier log-rank analysis (14 days) was used to compare survival curves between LM and MHC-MDA5 mice. Pairwise comparisons were performed using Mann-Whitney test; comparisons between >2 groups were performed by a 1-way ANOVA, and post hoc ANOVA testing (Fisher protected least significant difference [PLSD]) was performed where appropriate (StatView Adept Scientific Inc, Acton, MA).
Results
Characterization of αMHC-MDA5 Mice
We obtained 2 heterozygous founder lines ( Figure 1A ) that harbored cardiac-restricted overexpression of the MDA5 transgene (αMHC-MDA5): 1995 (≈5 copies) and 524 (≈25 copies). Both founder lines grew to adulthood without increased mortality. Western blot analysis of cardiac extracts from both founder lines confirmed increased myocardial expression of the c-myc-tagged MDA5 protein ( Figure 1B ). The αMHC-MDA5-1995 line was selected for further characterization and is referred to as αMHC-MDA5.
To determine whether cardiac-specific overexpression of MDA5 led to increased expression of cytokines in the heart, we performed ELISA to measure TNF, CXCL10, IFNβ, and IFNγ expression. As shown in Figure 1C , TNF, IFNβ, and IFNγ protein expression was significantly (P<0.05) increased in the hearts of αMHC-MDA5 mice compared with LM mice. In contrast, there were no differences in cardiac CXCL10 protein expression between the 2 groups of mice. Because overexpression on MDA5 led to production of type I IFN in the heart, we assessed whether this also led to expression on IFN-stimulated genes (ISGs). Figure 1D shows that αMHC-MDA5 mice had increased cardiac mRNA expression of Irf7, Mx-1, Isg15, and Oas2 compared with LM mice. Figure 2 summarizes the baseline assessment of cardiac structure and function in 6-week-old LM and αMHC-MDA5 mice. The heart weight to body weight ratio was not significantly different in the 2 groups of mice ( Figure 2A) . Similarly, cardiac function as measured by ejection fraction (% ejection fraction; Figure 2B and 2C) did not differ between the 2 groups. Cardiac troponin I was not detected in the sera of LM or αMHC-MDA5 mice at 6 weeks of age (data not shown).
Phenotypic Characterization of αMHC-MDA5 Mice (6 Weeks)
Heart sections were stained to assess for baseline pathological alterations in LM and αMHC-MDA5 mice. The overexpression of MDA5 resulted in spontaneous cellular infiltrates in the myocardium of αMHC-MDA5 mice ( Figure 2D ). The percentage of infiltrating CD45 + cells ( Figure 2E ) was significantly greater in the hearts of αMHC-MDA5 (2.6±0. 4%) compared with LM controls (0.7±0.15%; P<0.05). Despite increased myocardial expression of TNF, ISGs, and spontaneous white cell infiltration, no obvious cardiomyocyte disarray, necrosis, or cardiac dysfunction was noted in αMHC-MDA5 mice.
αMHC-MDA5 Mice Exhibit Decreased Susceptibility to EMCV-Induced Mortality
To determine whether cardiac-specific overexpression of MDA5 affected the susceptibility to virus-mediated lethality and cardiac injury, we challenged LM (n=25), αMHC-MDA5 (n=25), and MDA5-KO (n=25) mice with a myocarditic variant of EMCV. EMCV-infected MDA5-KO mice had significantly earlier mortality compared with αMHC-MDA5 transgenic mice and their LM controls ( Figure 3 ). By day 4 after infection, 100% of MDA5-KO mice were dead. In contrast, 100% of αMHC-MDA5 and 60% of LM were alive at day 4 after infection. By day 14 after infection, 15% of LM and 46% of αMHC-MDA5 mice were alive. Kaplan-Meier analysis showed a significant (P<0.05) difference in the 14-day survival between LM and αMHC-MDA5 mice.
Cardiac-Specific MDA5 Expression Attenuates Severity of Myocarditis
To determine whether MDA5 overexpression also affected the severity of myocarditis in EMCV-infected mice, quantification of CD45 + cells was performed at 3, 5, and 14 days after infection. Figure 4A and 4B shows an increase (P<0.05) in the percentage of CD45 + cells in the hearts of both LM and αMHC-MDA5 mice at 3, 5, and 14 days after infection. However, the degree of myocardial inflammation was significantly greater in EMCV-infected LM mice. When baseline differences in cardiac CD45 + cells were taken into consideration, the fold change in CD45 + cells was significantly greater in LM mice (data not shown). We performed immunohistochemisty for CD4, CD8, CD206 (M2), and CD11c (M1), as well as quantitative polymerase chain reaction on hearts from both groups. Before EMCV infection, there was a paucity of all cell types in the hearts of LM mice ( Figure IA in the onlineonly Data Supplement). At baseline, the cellular infiltrate in the hearts of αMHC-MDA5 mice was primarily composed of CD11c (M1 phenotype) and CD8 + T cells. These findings were also supported by the quantitative polymerase chain reaction data ( Figure IB in the online-only Data Supplement). We also noted marked staining for CD206 (M2 phenotype) macrophages in the hearts of αMHC-MDA5 mice, despite a very modest increase in CD206 mRNA expression. After infection, there was a dramatic increase in CD8 + T cells and CD11c (M1 phenotype) in the hearts of LM mice ( Figure  IIA in the online-only Data Supplement). In contrast, these increases were dampened in the hearts of αMHC-MDA5 mice. Interestingly, we noted decreased staining of CD206 + cells (M2 phenotype) in the hearts of LM mice at day 3 after infection compared with αMHC-MDA5 mice. A similar trend was noted for CD206 mRNA expression ( Figure IIB in the online-only Data Supplement). Figure 5 shows that cardiac protein levels of CXCL10 and IFNβ were significantly increased in the hearts of LM mice at days 3 and 5 after infection. In contrast, the TNF protein levels were significantly higher in the hearts of infected αMHC-MDA5 mice. In addition, there was a trend toward higher INFγ levels at days 3 and 5 after infection in the hearts of αMHC-MDA5 mice. Figure 5B also shows that cardiac mRNA expression of Irf7, Mx-1, Isg15, and Oas2 increased in both LM and αMHC-MDA5 mice after infection. However, the changes were significantly higher in the hearts of LM mice. These data suggest that increased baseline expression of antiviral mediators modulated the response mounted by the infected host cell in αMHC-MDA5 mice.
Decreased Virus Replication and Myocardial Injury in MDA5 Transgenic Mice
To assess the biological significance of cardiac-restricted MDA5 overexpression, we measured cardiac viral load after infection. Figure 6A shows that LM and MDA5-KO mice had significantly (P<0.5) higher viral loads in the heart at 3 days after infection compared with αMHC-MDA5 mice. EMCV titers were 100-fold and 1000-fold higher in the hearts of EMCVinfected LM and MDA5-KO mice at 3 days, respectively. By day 5 after infection, viral replication was decreasing in the hearts of both LM and αMHC-MDA5 mice, but they were still significantly higher in LM mice ( Figure 6A ). EMCV titers in the liver were not significantly different between LM and αMHC-MDA5 mice at day 3 (3.4±0.05 versus 3.2±0.05 PFU log 10 /mg tissue). In contrast, on day 3 after EMCV infection, viral load in the livers of MDA5-KO (4.2±0.30 versus 3.2±0.05 PFU log 10 /mg tissue) mice was 10-fold higher than in LM or αMHC-MDA5 livers. To determine whether decreased mortality in the αMHC-MDA5 mice was associated with decreased myocardial injury, we measured serum cardiac troponin I levels on days 3 and 5 after infection. We found that on days 3 and 5 after infection, serum cardiac troponin I levels were significantly lower in αMHC-MDA5 mice compared with that in LM mice ( Figure 6B ). This suggested that cardiac overexpression of MDA5 attenuated viral-induced cell lysis.
To determine whether MDA5 overexpression in the cardiac myocyte is sufficient to affect cardiac function after EMCV infection, echocardiography was performed before and at 4 and 7 days after infection. LV function was normal in both LM and αMHC-MDA5 mice before infection. At 4 days after EMCV infection, LV function and end-systolic dimensions were near normal in both groups ( Figure 6C ). By day 7 after infection, there was a significant decrease in the ejection fraction and an increase in chamber dilation in LM mice. The latter was manifested as a significant increase in LV end-systolic dimension ( Figure 6C and 6D) . Thus, cardiac myocytespecific overexpression of MDA5 resulted in a significant decrease in virus replication and myocardial injury, leading to preservation of LV function. These data suggest that MDA5 signaling within the cardiac myocyte is an important innate antiviral defense mechanism.
EMCV-Induced Myocyte Apoptosis Is Attenuated in MDA5 Transgenic Mice
MDA5 has been shown to initiate a proapoptotic signaling pathway that is independent of type I IFNs. 12 From this point of view, the MDA5-mediated induction of apoptotic signaling during viral infection could represent a defense strategy of the host that counteracts the antiapoptotic activities of the invading pathogen. To determine whether cardiac-specific overexpression of MDA5 was sufficient to induce apoptosis, we compared the prevalence of apoptotic cardiac nuclei in 6-week-old αMHC-MDA and LM control mice. Figure 7A and 7B shows that the prevalence of cardiomyocyte apoptosis was higher (0.0125 versus 0.025; P<0.05) at baseline in αMHC-MDA5 than in LM mice. Importantly, these differences in baseline apoptosis did not lead to changes in myocardial structure or function ( Figure 2 ). After infection (days 3 and 5), the prevalence of cardiomyocyte apoptosis increased significantly in both groups. However, the increase in apoptotic nuclei was more dramatic in LM-infected mice ( Figure 7A and 7B) . We also assessed caspase 3 cleavage by Western blot as another measure of apoptosis. No significant differences in the baseline levels of cleaved caspase 3 ( Figure 7C and 7D) were noted between LM and αMHC-MDA5 mice. EMCV infection (days 3 and 5) induced a significant increase in the levels of cleaved caspase 3 in the hearts of both LM and αMHC-MDA5 mice. In agreement with the TUNEL staining data, the changes in cleaved caspase 3 were more pronounced in the hearts of EMCV-infected LM mice.
Cardiac-Specific Overexpression of MDA5 Prolongs Survival in MDA5 Knockout Mice
To further define the role of cardiac MDA5 expression, MDA5-KO mice were interbred with animals overexpressing an MDA5 transgene (αMHC-MDA5) exclusively in the heart. MDA5-KO mice develop severe myocarditis and experience 100% early lethality (days 3-4). 6, 7 Survival after EMCV infection was compared between MDA5-KO and αMHC-MDA5/MDA5-KO double-mutant mice. Figure 8A depicts the survival curves of the 2 strains of animals. Cardiac expression of MDA5 markedly enhanced the 14-day survival of MDA5-KO mice. That is, survival improved in MDA5-KO mice from 0% to 21% and was similar to the survival of EMCV-infected LM mice (15%; Figure 3 ). Furthermore, cardiac viral load in αMHC-MDA5/MDA5-KO doublemutant mice was 10× lower compared with MDA5-KO mice ( Figure 8B ). Figure 8C shows that there was a trend toward lower cardiac troponin levels in αMHC-MDA5/MDA5-KO double-mutant mice. 
Discussion
Viral infections of the heart are an important cause of heart failure. Although the discovery and characterization of retinoic-induced gene-I-like receptors has led to a better understanding of the innate immune system, the mechanisms that contribute to host defense against viral infection in the cardiac myocyte are only partially understood. Recent studies have shown that global loss of function of either MDA5 or its adaptor molecule Mitochondrial antiviral signaling adaptor (MAVS) increases the susceptibility of adult mice to EMCV-and CBV3-induced mortality and multiorgan failure (pancreas, liver, and heart). 6, 7, 9 However, the aforementioned studies with total knockout mice cannot be used as evidence to support the importance of cardiac MDA5 signaling in the pathogenesis of viral myocarditis. Here, we have taken a genetic approach to examine the role of MDA5, within cardiomyocytes, in the development of acute EMCV-induced myocarditis. Our characterization of αMHC-MDA5 mice shows that overexpression of MDA5 in cardiomyocytes can lead to spontaneous baseline expression of cardiac cytokines, including TNF, INFβ, IFNγ, and ISGs. Baseline expression of these mediators was associated with mild cardiac inflammation but no evidence of cardiac dysfunction ( Figure 1) . The results from the present study show for the first time that cardiac-specific overexpression of MDA5 attenuates EMCV-induced mortality, cardiac viral replication, myocarditis, and cardiac myocyte apoptosis and results in the prevention of LV dysfunction and cardiac dilation after infection. Furthermore, cardiac-targeted expression of MDA5 improved 14-day survival by 21% in MDA5-KO mice. Using a similar transgenic approach we have previously shown that cardiac-specific overexpression of the TLR3/TLR4 adaptor molecule TRIF protected cardiac myocytes from direct EMCV injury and attenuated cardiac dysfunction. 10 Interestingly, cardiac-specific TRIF transgenic mice exhibited increased baseline expression of the retinoic-induced gene-I-like receptors MDA5 and LGP2, suggesting that these molecules may synergize to control EMCV replication in the heart. In support of this point of view, recent studies have shown that both dengue virus and rhinovirus require cotriggering of TLR3/TRIF and MDA5 to induce an adequate innate immune response to control viral replication. 13, 14 Although the mechanisms for the resistance to EMCV infection in αMHC-MDA5 mice are yet to be completely defined, the observed increased baseline expression of TNF, INFγ, INFβ, and ISG may explain this effect because EMCV replication has been shown to be inhibited by their antiviral effects. The exogenous administration of TNF or INFβ has been shown to modify the severity of EMCV-or CVB3induced myocarditis in mice. [15] [16] [17] However, the protective effects in the heart after administration of a single agent do not seem to be complete. Wessely et al 18 reported that type I IFN signaling played an essential role in preventing early CVB3 replication in the liver but had little effect on early viral replication in the heart. These findings questioned the role of endogenous type I IFN signaling in the control of viral replication in the heart. However, Riad et al 15 have recently shown that exogenous administration of IFNβ improves survival and decreases CVB3 replication in TRIF knockout mice. Although the role of IFNβ in the treatment of patients with acute viral myocarditis remains unclear, a recent study has suggested that INFβ may be beneficial in the treatment of chronic viral cardiomyopathy. 19 In the present study, MDA5 overexpression had a marked effect on cardiac viral replication and cardiac injury, suggesting that the early presence of multiple cytokines, such as TNF, IFN-β, IFN-γ, and ISGs, may be required to effectively protect the cardiac myocyte against direct viral injury. The factors that may affect the expression levels of MDA5 in the heart are unknown. Although there have been no studies describing any associations between MDA5 mutations and host susceptibility to viral myocarditis, there have been reports linking mutations in IFIH1 (MDA5) to type I diabetes mellitus. [20] [21] [22] Resistance to type I diabetes mellitus is associated with polymorphisms that reduce MDA5 protein expression and impair the function of MDA5. Whether the presence of these single-nucleotide polymorphisms will have any effect on the pathogenesis of viral heart disease is unknown. The induction of apoptosis is an innate immune mechanism by which host cells protect themselves from lytic viruses, such as EMCV. 23 Signaling through MDA5 and its adaptor molecule MAVS has been shown to induce apoptosis in many cells. 12, 24 Interestingly, picornaviruses have evolved strategies to manipulate the cellular apoptotic machinery with the goal of prolonging the survival of the infected cell, 25, 26 which in turn helps the virus to complete its life cycle. From this point of view, the MDA5-mediated induction of apoptotic signaling reflects a defense strategy of the host that counteracts the antiapoptotic activities of the invading pathogen. However, experimental 27, 28 and clinical studies have shown that virus-induced cardiomyocyte apoptosis also has a deleterious effect on LV function, leading to severe heart failure and, in severe cases, death. [29] [30] [31] In the present study, EMCV-induced cardiac myocyte apoptosis and caspase 3 cleavage were attenuated in αMHC-MDA5 transgenic mice compared with infected LM controls. The decreased prevalence of apoptosis and caspase 3 cleavage in αMHC-MDA5 mice can be explained, at least in part, by the significantly lower viral loads in the hearts of these mice. From a pathophysiological standpoint, the LV dysfunction observed in LM-infected mice is likely the result of ongoing viral replication and progressive cardiomyocyte apoptosis.
The results from this study have highlighted the beneficial effects of MDA5 signaling in the adult mammalian heart. However, after resolution of the acute infection MDA5 activation may represent a mixed blessing for the heart. That is, the controlled self-limited activation of this pathway is critical in activating host defense mechanisms (TNF, INFβ, and IFNγ) in the heart, but uncontrolled and prolonged activation of MDA5 signaling may produce devastating consequences leading to persistent inflammation, myocardial dysfunction, dilated cardiomyopathy, and death. For example, mice with targeted overexpression of TNF in the cardiac compartment develop florid myocarditis, progressive myocardial fibrosis, and heart failure. [32] [33] [34] Similarly, IFNγ transgenic mice also develop dilated cardiomyopathy and a reduction in fractional shortening that is mediated through increased production of TNF. 35 Interestingly, Crampton et al 36 recently reported that MDA5 transgenic mice have increased levels of type I IFN and ISGs and are resistant to infection with vesicular stomatitis virus, but do not spontaneously develop autoimmune or inflammatory pathology. These results are in agreement with what we have reported here, except that αMHC-MDA5 mice do show spontaneous production of cardiac inflammatory cytokines (TNF and interleukin 1) but do not develop myocardial dysfunction at 6 weeks of age.
In conclusion, targeted expression of MDA5 in the cardiac myocyte prevents EMCV-induced contractile dysfunction and is associated with decreased cardiac viral replication, less severe myocarditis, and a decreased prevalence of cardiac myocyte apoptosis. Interestingly, we observed a trend toward an M2 macrophage phenotype that could potentially promote repair while limiting secondary inflammatory-mediated injury in αMHC-MDA5 mice. Furthermore, the significant improvement in survival in αMHC-MDA5/MDA5-KO mice compared with MDA5-KO mice provides further evidence of the importance of MDA5 signaling in the heart in the setting of acute viral myocarditis. More importantly is the fact that the protective effects were noted, despite continued viral replication in the livers of the αMHC-MDA5/MDA5-KO mice. The important question that arises from this study is whether it will be possible to modulate the potential maladaptive consequences of MDA5 activation and proinflammatory cytokine expression while preserving the beneficial antiviral effects. It seems plausible that even after resolution of the infection the persistent activation of the MDA5 pathway may lead to pathological consequences. The answer to this important question will come from the longitudinal observation of αMHC-MDA5 mice.
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CLINICAL PERSPECTIVE
Viral infections of the heart are an important cause of heart failure in both children and adults. To date, the mechanisms underlying why some individuals are more susceptible to cardiotropic viruses than others are not well established. Specifically, what are the host genetic factors that control early viral replication and virus-induced cytopathic effects in the heart? The RNA helicase melanoma differentiation associated gene-5 (MDA5) is critical for host antiviral responses against members of the Picornaviridae family. The data in this study demonstrate that an MDA-5-dependent antiviral defense mechanism within the cardiac myocyte can affect susceptibility to viral myocarditis. That is, targeted expression of MDA5 in the cardiac myocyte prevents virus-induced contractile dysfunction and is associated with decreased cardiac viral replication, less severe myocarditis, and a decreased prevalence of cardiac myocyte apoptosis. The factors that may affect the expression levels of MDA5 in the heart are unknown. Although there have been no studies describing any associations between MDA5 mutations and host susceptibility to viral myocarditis, there have been reports linking IFIH1 (MDA5) to type I diabetes mellitus. Whether the presence of single-nucleotide polymorphisms in MDA5 will have any effect on the clinical outcome of viral heart disease remains to be determined.
